CytomX Therapeutics, Inc. CTMX
CTMX
CytomX Therapeutics, Inc. ERAS
Erasca, Inc. IOVA
Iovance Biotherapeutics, Inc. MBX
MBX Biosciences, Inc. Common Stock AVBP
ArriVent BioPharma, Inc. Common Stock MGTX
MeiraGTx Holdings plc ATXS
Astria Therapeutics, Inc. MLTX
MoonLake Immunotherapeutics REPL
Replimune Group, Inc. DNA
Ginkgo Bioworks Holdings, Inc.
CytomX Therapeutics, Inc. ERAS
Erasca, Inc. IOVA
Iovance Biotherapeutics, Inc. MBX
MBX Biosciences, Inc. Common Stock AVBP
ArriVent BioPharma, Inc. Common Stock MGTX
MeiraGTx Holdings plc ATXS
Astria Therapeutics, Inc. MLTX
MoonLake Immunotherapeutics REPL
Replimune Group, Inc. DNA
Ginkgo Bioworks Holdings, Inc.
Performance
| Periode | CTMX | ERAS | IOVA | MBX | AVBP | MGTX | ATXS | MLTX | REPL | DNA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 77.82 % | 563.89 % | -0.45 % | 229.12 % | 0.00 % | -11.30 % | 102.37 % | -68.87 % | -42.20 % | -0.21 % |
| YTD | 0.00 % | 166.30 % | -11.90 % | 33.91 % | 5.29 % | -1.54 % | -0.62 % | 36.82 % | -17.98 % | 10.11 % |
| 1Y | 401.71 % | 413.98 % | -61.46 % | 288.14 % | -10.54 % | 29.68 % | 65.29 % | -60.57 % | -29.54 % | -6.08 % |
| 3Y | 59.18 % | 137.81 % | -65.47 % | 72.98 % | 9.50 % | 11.29 % | -9.60 % | 33.03 % | -73.72 % | -87.96 % |
| 5Y | -49.88 % | -45.15 % | -95.64 % | 72.98 % | 9.50 % | -52.62 % | -19.74 % | 48.91 % | -82.90 % | -97.63 % |
| 10Y | -66.30 % | -45.15 % | -60.14 % | 72.98 % | 9.50 % | -48.73 % | -96.08 % | 55.86 % | -51.85 % | -97.63 % |
| From the beginning | -67.05 % | -45.15 % | -97.98 % | 72.98 % | 9.50 % | -48.73 % | -98.36 % | 55.86 % | -51.85 % | -97.63 % |